XBiotech Inc.
XBiotech Inc. (XBIT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · XBIT · as of Jun 9, 2026
Key Statistics
Explore XBiotech Inc. Data
xbit stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 100.0%
Competitors & Peers
xbit competitorsXBIT
ACET
ACRV
ADAG
CRVO
FBIOStock Performance
Full HistoryAbout XBiotech Inc.
XBiotech Inc. is a biopharmaceutical firm specializing in the discovery, development, and commercialization of True Human monoclonal antibodies. Their primary focus involves building a robust pipeline…
what is xbiotech inc. · xbit stock overview · xbiotech inc. company profile · who is xbiotech inc. ceo · xbit NASDAQ · xbiotech inc. headquarters · xbiotech inc. business segments
About Stock Overview & Key Data
XBiotech Inc. (XBIT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 15, 2015. As of the latest trading session, XBIT stock price is $2.37, with a market capitalization of $72.3M. The stock has returned -19.39% over the past 12 months and -0.84% year-to-date.
According to 3 Wall Street analysts, the consensus rating for XBiotech Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, XBiotech Inc. reported revenue of — and net income of -$45.5M. For detailed data — including XBiotech Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, XBiotech Inc. (XBIT) stock price is $2.37. The stock is traded on NASDAQ under the ticker symbol XBIT. The 52-week range is $2.09 – $3.61.